Article: Battle for generics.(News)

FEW changes would do more to reduce healthcare costs quickly than making generic medications more widely available. Which is why bad news for Bristol-Myers Squibb could be good news for everyone else.

Late last month, federal investigators raided the drug giant's New York offices looking for evidence that it had struck an illegal deal with a competitor to delay the launch of a generic version of the world's second-bestselling drug. On Tuesday, that competitor announced that it planned to start selling the drug anyway. Shares of Bristol-Myers fell almost 7% on the news.

Drug manufacturers such as Bristol-Myers have been under increasing financial pressure ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!